APOLLO HOSPITALS ENTER. L vs ERIS LIFESCIENCES LIMITED

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and ERIS LIFESCIENCES LIMITED (ERIS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

APOLLO HOSPITALS ENTER. L and ERIS LIFESCIENCES LIMITED are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
32.54
13.42
P/B ratio
5.14
0.11%
Dividend yield
0.50%
₹135.04
EPS
₹44.72

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
18.70%
18.00%
Return on capital
14.00%
15.00%
EBITDA margin
36.00%
7.94%
Net margin
20.71%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
22.91%
33.39%
Profit CAGR (3Y)
20.11%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹20,154 Cr
₹25,228 Cr
Revenue
₹3,129 Cr
₹2,003 Cr
Net profit
₹648 Cr
0.90
Debt / equity
0.60
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
ERIS LIFESCIENCES LIMITED
  • ["Stock is trading at 5.08 times its book value", "Promoter holding has decreased over last quarter: -0.93%", "Tax rate seems low"]
APOLLO HOSPITALS ENTER. L full analysis ERIS LIFESCIENCES LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLO HOSPITALS ENTER. L vs ERIS LIFESCIENCES LIMITED: Share Price, Valuation & Which to Buy | DocStoX